December 12, 2024 - 23:25

President-elect Donald Trump has made a bold promise regarding the deportation of migrants, stating that he would utilize military force to expel individuals back to their countries of origin. This announcement marks a significant stance in his immigration policy, emphasizing a tough approach to border control and national security. Trump further declared that he would refuse to engage in any business dealings with countries that do not agree to accept their citizens back once they are deported.
This approach has raised eyebrows among political analysts and human rights advocates, who question the implications of using military resources in such a manner. Critics argue that this policy could strain international relations and complicate diplomatic efforts. Supporters, however, view it as a necessary measure to uphold the rule of law and deter illegal immigration.
As the nation prepares for a new administration, Trump's statements have sparked widespread debate over the future of immigration policy and the role of military intervention in domestic issues.
June 27, 2026 - 07:59
Gilbert Chamber Foundation brings AI basics to local businessesBusiness owners in Gilbert and the East Valley are getting a hands-on look at how artificial intelligence could keep them competitive. The Gilbert Chamber Foundation has introduced a new initiative...
June 26, 2026 - 18:02
Meet ‘Pepper’ Baumer, The Man With Hot Sauce In His BloodHot sauce has become one of the fastest-growing sectors in the food industry, and few people understand that heat better than `Pepper` Baumer. As the third-generation owner of Crystal, a...
June 26, 2026 - 11:50
‘Disgusting and vile’: Locals react to arrest of Tampa business owner on AI child porn chargesA Tampa business owner is behind bars this week, facing more than 100 felony charges after authorities say he used artificial intelligence to create child pornography. Local residents and fellow...
June 25, 2026 - 20:17
Investigational heart drug for nonobstructive HCM one step closer to FDA approvalAn experimental oral medication for a specific type of hypertrophic cardiomyopathy is advancing toward potential U.S. approval. The drug, known as ninerafaxstat, is being developed for patients...